⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14597952 | 0.92 | PKM (0.42) | — | |
| SCHEMBL5488684 | 0.90 | TSHR (0.37) | — | |
| SCHEMBL11822842 | 0.81 | PKM (0.46) | — | |
| SCHEMBL5487504 | 0.78 | CYP3A4 (0.46) | — | |
| SCHEMBL5603683 | 0.78 | CYP3A4 (0.52) | — | |
| SCHEMBL5491386 | 0.78 | CYP3A4 (0.46) | — | |
| SCHEMBL12192204 | 0.77 | — | — | |
| SCHEMBL14033143 | 0.77 | CA2 (0.39) | — | |
| SCHEMBL13510936 | 0.75 | — | — | |
| SCHEMBL8041879 | 0.75 | LPAR3 (0.48) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9024014-B2 | Phosphorus-containing compounds and uses thereof | ARIAD PHARMACEUTICALS, INC. (US) | 2015-05-05 | — | — | US | disclosed |
| US-9024014-B2 | Phosphorus-containing compounds and uses thereof | ARIAD PHARMACEUTICALS, INC. (US) | 2015-05-05 | — | — | US | disclosed |
| US-20120178714-A1 | Phosphorus-containing Compounds & Uses Thereof | ARIAD PHARMACEUTICALS, INC. (US) | 2012-07-12 | — | — | US | disclosed |
| US-8058426-B2 | Phosphorus-containing compounds and uses thereof | ARIAD PHARMACEUTICALS, INC. (US) | 2011-11-15 | — | — | US | disclosed |
| US-20100197907-A1 | Phosphorus-containing compounds & uses thereof | ARIAD PHARMACEUTICALS, INC. (US) | 2010-08-05 | — | — | US | disclosed |
| US-7709020-B2 | Rapamaycin derivatives used as fungicides, anticarcinogenic agents, immunosuppressants or as coatings on drug eluting stents to prevent restenosis | ARIAD PHARMACEUTICALS, INC. (US) | 2010-05-04 | — | — | US | disclosed |
| US-7468225-B2 | Non-aqueous electrolyte secondary battery | PANASONIC CORPORATION (JP) | 2008-12-23 | — | — | US | disclosed |
| US-20070218370-A1 | NonAqueous Electrolyte Secondary Battery | PANASONIC CORPORATION (JP) | 2007-09-20 | — | — | US | disclosed |
| US-20070190106-A1 | Phosphorus-containing compounds & uses thereof | MEDINOL LTD. (IL) | 2007-08-16 | — | — | US | disclosed |
| US-7238679-B2 | Heterocycles and uses thereof | ARIAD PHARMACEUTICALS, INC. (US) | 2007-07-03 | — | — | US | disclosed |
| US-7186826-B2 | Phosphorus-containing compounds and uses thereof | ARIAD GENE THERAPEUTICS, INC. (US) | 2007-03-06 | — | — | US | disclosed |
| US-20070009804-A1 | Heteroatomic polymers as safer electrolytes for magnesium batteries | DIXON BRIAN G | 2007-01-11 | — | — | US | disclosed |